InsidersTradesSigma
Follow the 凯普生物 share price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 凯普生物 has published 3 public disclosures. Market capitalisation: €3.5bn. The latest transaction was reported on 9 January 2026 (Purchase). Among the most active insiders: 谢龙旭. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
凯普生物 is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical solutions. It is listed on the XSHE market.